Concerns that four syrups identified by the World Health Organization (WHO) as possibly contributing to the deaths of children in Kenya have been resolved by the government.
Pharmacy and Poisons Board (PPB) released a statement on October 7 reiterating that medicines associated with an Indian company had not reached the Kenyan market.
The government agency stressed that there was no need for concern among the Kenyan people. Parents, however, were cautioned to be on the alert for these syrups.
The World Health Organization warned against using Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup, and Magrip N Cold Syrup because they include ingredients linked to genetic disorders.
In addition, the government gave Kenyans a USSD code (*271#) they may use to report potentially dangerous medicines.